Catalog #CP205

RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)

Clone 9H10-CP205
Reactivities Mouse
Isotype Mouse IgG2a (LALA-PG), κ
(switched from Syrian hamster IgG)

$560.00 - $14,859.50

$560.00 - $14.00

Choose an Option...
  • 100 mg - $14,859.50
  • 50 mg - $10,614.00
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

The 9H10-CP205 monoclonal antibody is a chimeric version of the original 9H10 antibody. The variable domain sequences are identical but the constant region sequences have been switched from Syrian hamster IgG1 to mouse IgG2a, κ. The constant region includes the Fc silencing mutation variants LALA-PG, rendering it unable to bind endogenous murine Fcγ receptors or C1q to induce antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). 9H10-CP205 is useful to evaluate pure CTLA-4 blockade (antagonism) without Fc-dependent depletion of regulatory T cells (Tregs) or other effector functions. Species-matched chimeric antibodies result in less immunogenicity and formation of anti-drug antibodies (ADAs) than xenogenic antibodies in animal models. The highly controlled sequence and lack of genetic drift in recombinant antibodies provide more reliable and reproducible results over hybridoma derived antibodies.

9H10-CP205 reacts with mouse CTLA-4 (cytotoxic T lymphocyte antigen-4) also known as CD152. CTLA-4 is a 33 kDa cell surface receptor encoded by the Ctla4 gene that belongs to the CD28 family of the Ig superfamily. CTLA-4 is expressed on activated T and B lymphocytes. CTLA-4 is structurally similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to the B7 family members B7-1 (CD80) and B7-2 (CD86). Upon ligand binding, CTLA-4 negatively regulates cell-mediated immune responses. CTLA-4 plays roles in induction and/or maintenance of immunological tolerance, thymocyte development, and regulation of protective immunity. CTLA-4 is among a group of inhibitory receptors being explored as cancer treatment targets through immune checkpoint blockade.

Specifications

Isotype Mouse IgG2a (LALA-PG), κ
Recommended Isotype Control(s) RecombiMAb mouse IgG2a (LALA-PG) isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Conjugation This product is unconjugated. Conjugation is available via our Antibody Conjugation Services.
Mutations LALA-PG
Immunogen Mouse CTLA-4-human IgG1 fusion protein
Reported Applications in vivo CTLA-4 neutralization*
in vitro CTLA-4 neutralization*
Western blot
*Reported for the original Syrian hamster IgG 9H10 antibody
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from mammalian cell supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Additional Formats

  1. Catalog #BE0131
    InVivoMAb anti-mouse CTLA-4 (CD152) Read more
  2. Catalog #BP0131
    InVivoPlus anti-mouse CTLA-4 (CD152) Read more
  3. Catalog #CP146
    RecombiMAb anti-mouse CTLA-4 (CD152) Read more
  4. Catalog #CP204
    RecombiMAb anti-mouse CTLA-4 (CD152) Read more